| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Chief Executive Officer
1 company
Evans John M. is a CEO at BEAM. Recent filings cover 0 purchases and 86 sales. Those positions are worth an estimated $25.1M at current prices.
Our model assigns Evans John M. a strong insider score of 70/100, based on 19 past trades. Over a 12-month horizon, 70.6% of those trades were profitable, with an average 12-month return of +23.9%.
Evans John M.'s largest disclosed position is in BEAM as CEO, worth about $25.1M. The recent filings there lean toward selling, a net 776,680 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 50,000 | $23.77 | $1,188,745.00 | -4.6% | - | - | |
| Jun 30, 2026 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 50,000 | $34.90 | $1,745,037.20 | -4.6% | - | - | |
| Oct 2, 2025 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 50,000 | $24.57 | $1,228,322.50 | -4.8% | +8.3% | - | |
| Apr 1, 2025 | BEAM Beam Therapeutics Inc. | CEO | Sell | 30,663 | $18.35 | $562,684.45 | -3.0% | -3.5% | +37.3% | |
| Jan 30, 2025 | BEAM Beam Therapeutics Inc. | CEO | Sell | 30,000 | $26.75 | $802,483.82 | -3.2% | -26.9% | +1.2% | |
| Sep 30, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $24.60 | $1,476,024.00 | -6.0% | +3.1% | -0.9% | |
| Jun 27, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $24.50 | $1,470,156.00 | -5.7% | +2.2% | -29.9% | |
| Apr 1, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 18,102 | $32.13 | $581,617.26 | -1.7% | -29.4% | -46.0% | |
| Mar 28, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $33.86 | $2,031,402.00 | -5.7% | -24.8% | -32.8% | |
| Jan 31, 2024 | BEAM Beam Therapeutics Inc. | CEO | Sell | 60,000 | $25.33 | $1,519,800.00 | -5.4% | -13.0% | +11.8% |